Antibody Response after COVID-19 Vaccination in Intravenous Immunoglobulin-Treated Immune Neuropathies
Description
CONCLUSIONS: Our study indicates that IVIg does not impair the antibody response to COVID-19 mRNA vaccine in a short-term observation, when administered a minimum of two weeks after each vaccine dose. The infusion of current IVIg preparations that
